Results 121 to 130 of about 259,605 (285)
British Journal of Clinical Pharmacology, EarlyView.Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley +1 more source
American and European legislation on border medical devices
Introduction Borderline medical devices are products in a 'gray area,' this means due to their characteristics, they could belong to different 'legal products.' In addition, regulation is a controversial topic and may change depending on the country ...
Nácher Alonso, Amparo +3 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims In medical education, the ability of large language models (LLMs) to match human performance raises questions about their potential as educational tools. This study evaluates LLMs' performance on Clinical Pharmacology and Therapeutics (CPT) exams, comparing their results to medical students and exploring their ability to identify poorly formulated
Alexandre O. Gérard +11 more
wiley +1 more source
Regulatory Science: exploring an emerging scientific discipline in health care
Frontiers in MedicineRegulatory Science has gained increasing prominence in the regulatory community, yet its character as a scientific discipline remains insufficiently clarified.
Laura Volpi +5 more
doaj +1 more source
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption [PDF]
To date, 16 states have passed medical marijuana laws, yet very little is known about their effects. Using state-level data, we examine the relationship between medical marijuana laws and a variety of outcomes.
Anderson, D. Mark, Rees, Daniel I.
core
Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics
British Journal of Clinical Pharmacology, EarlyView.Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay +5 more
wiley +1 more source
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
(A) study on reasonable legislation of the quasi-medical services
, 2009 보건정책관리학과/석사[한글] 본 연구는 의료행위로서 현재 법의 사각지대에 놓여있고 우리 생활 주변에 보편화되어 있는 유사(대체)의료행위 일부에 대하여 허용할 수 있는 대상, 범위 및 입법방안을 검토하고 입법 시에 들어가야 할 주요내용들을 고찰함으로써 향후 보건의료정책의 입법방향이나 법제화의 기초 자료로 활용하기 위함이다.
황대능
core
Immigrants and healthcare in Bulgaria: the responses by policy and legislation
, 2009 The global scale of international migration flows has pushed migrants` health issues high up the policy agenda as worldwide. Bulgaria as a new EU member-state is increasingly affected by immigration pressure.
Kerekovska, Albena; Medical University of Varna +1 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source